AAAAAA
Results: 1-25/71
Authors:
Ferrajoli, A
Manshouri, T
Estrov, Z
Keating, MJ
O'Brien, S
Lerner, S
Beran, M
Kantarjian, HM
Freireich, EJ
Albitar, M
Citation: A. Ferrajoli et al., High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia, CLIN CANC R, 7(4), 2001, pp. 795-799
Authors:
Aboul-Nasr, R
O'Brien, S
Freireich, EJ
Ginsberg, CF
Kantarjian, HM
Koller, CA
Keating, MJ
Albitar, M
Citation: R. Aboul-nasr et al., "T-cell-rich B-cell lymphoproliferative disorder" of the bone marrow, LEUK LYMPH, 42(5), 2001, pp. 1023
Authors:
Dabaja, BS
O'Brien, SM
Kantarjian, HM
Cortes, JE
Thomas, DA
Albitar, M
Schlette, ES
Faderl, S
Sarris, A
Keating, MJ
Giles, FJ
Citation: Bs. Dabaja et al., Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoxome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome, LEUK LYMPH, 42(3), 2001, pp. 329-337
Authors:
Giles, FJ
Shen, Y
Kantarjian, HM
Korbling, MJ
O'Brien, S
Anderlini, P
Donato, M
Pierce, S
Keating, MJ
Freireich, EJ
Estey, E
Citation: Fj. Giles et al., Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long term survival, LEUK LYMPH, 42(1-2), 2001, pp. 67-73
Authors:
Fleming, RV
Kantarjian, HM
Husni, R
Rolston, K
Lim, J
Raad, I
Pierce, S
Cortes, J
Estey, E
Citation: Rv. Fleming et al., Comparison of amphotericin B lipid complex (ABLC) vs. AmBisome in the treatment of suspected or documented fungal infections in patients with leukemia, LEUK LYMPH, 40(5-6), 2001, pp. 511-520
Authors:
Thomas, DA
Kantarjian, HM
Citation: Da. Thomas et Hm. Kantarjian, The revitalization of thalidomide, ANN ONCOL, 12(7), 2001, pp. 885-886
Authors:
Thomas, DA
Kantarjian, HM
Citation: Da. Thomas et Hm. Kantarjian, Lymphoblastic lymphoma, HEMAT ONCOL, 15(1), 2001, pp. 51
Authors:
Kantarjian, HM
Citation: Hm. Kantarjian, Adult acute lymphocytic leukemia - Future research directions, HEMAT ONCOL, 15(1), 2001, pp. 207
Authors:
Kantarjian, HM
Hoelzer, D
Larson, RA
Citation: Hm. Kantarjian et al., Advances in the treatment of adult acute lymphocytic leukemia, part II - Preface, HEMAT ONCOL, 15(1), 2001, pp. XI-XI
Authors:
Giles, FJ
Cortes, JE
Baker, SD
Thomas, DA
O'Brien, S
Smith, TL
Beran, M
Bivins, C
Jolivet, J
Kantarjian, HM
Citation: Fj. Giles et al., Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia, J CL ONCOL, 19(3), 2001, pp. 762-771
Authors:
Albitar, M
Manshouri, T
Gidel, C
Croce, C
Kornblau, S
Pierce, S
Kantarjian, HM
Citation: M. Albitar et al., Clinical significance of fragile histidine triad gene expression in adult acute lymphoblastic leukemia, LEUK RES, 25(10), 2001, pp. 859-864
Authors:
Faderl, S
Gidel, C
Kantarjian, HM
Manshouri, T
Keating, M
Albitar, M
Citation: S. Faderl et al., Loss of heterozygosity on chromosome 5 in adults with acute lymphoblastic leukemia, LEUK RES, 25(1), 2001, pp. 39-43
Authors:
Kantarjian, HM
Talpaz, M
Santini, V
Murgo, A
Cheson, B
O'Brien, SM
Citation: Hm. Kantarjian et al., Homoharringtonine - History, current research, and future directions, CANCER, 92(6), 2001, pp. 1591-1605
Authors:
Giles, FJ
Kantarjian, HM
Kornblau, SM
Thomas, DA
Garcia-Manero, G
Waddelow, TA
David, CL
Phan, AT
Colburn, DE
Rashid, A
Estey, EH
Citation: Fj. Giles et al., Mylotarg(TM) (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation, CANCER, 92(2), 2001, pp. 406-413
Authors:
Kantarjian, HM
Shan, JQ
Smith, T
Talpaz, M
Kozuch, P
Rios, MB
Cortes, J
Giles, FJ
O'Brien, S
Citation: Hm. Kantarjian et al., Response to therapy is independently associated with survival prolongationin chronic myelogenous leukemia in the blastic phase, CANCER, 92(10), 2001, pp. 2501-2507
Authors:
Ravandi, F
Hayes, K
Cortes, J
Albitar, M
Glassman, A
Talpaz, M
Kantarjian, HM
Citation: F. Ravandi et al., Translocation t(17;18)(q10;q10) - A new nonrandom chromosomal translocation of clonal evolution in chronic myeloid leukemia, CANCER, 91(9), 2001, pp. 1704-1708
Authors:
Ravandi, F
Kantarjian, HM
Talpaz, M
O'Brien, S
Faderl, S
Giles, FJ
Thomas, D
Cortes, J
Andreeff, M
Estrov, Z
Rios, MB
Albitar, M
Citation: F. Ravandi et al., Expression of apoptosis proteins in chronic myelogenous leukemia - Associations and significance, CANCER, 91(11), 2001, pp. 1964-1972
Authors:
Talpaz, M
O'Brien, S
Rose, E
Gupta, S
Shan, JQ
Cortes, J
Giles, FJ
Faderl, S
Kantarjian, HM
Citation: M. Talpaz et al., Phase 1 study of polyethylene glycol formulation of interferon alpha-2B (Schering 54031) in Philadelphia chromosome-positive chronic myelogenous leukemia, BLOOD, 98(6), 2001, pp. 1708-1713
Authors:
Estey, EH
Thall, PF
Cortes, JE
Giles, FJ
O'Brien, S
Pierce, SA
Wang, XM
Kantarjian, HM
Beran, M
Citation: Eh. Estey et al., Comparison of idarubicin plus ara-C-, fludarabine plus ara-C-, and topotecan plus ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts, BLOOD, 98(13), 2001, pp. 3575-3583
Authors:
Ibrahim, S
Keating, M
Do, KA
O'Brien, S
Huh, YO
Jilani, I
Lerner, S
Kantarjian, HM
Albitar, M
Citation: S. Ibrahim et al., CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia, BLOOD, 98(1), 2001, pp. 181-186
Authors:
Santini, V
Kantarjian, HM
Issa, JP
Citation: V. Santini et al., Changes in DNA methylation in neoplasia: Pathophysiology and therapeutic implications, ANN INT MED, 134(7), 2001, pp. 573-586
Authors:
Ibrahim, S
Estey, EH
Pierce, S
Glassman, A
Keating, M
O'Brien, S
Kantarjian, HM
Albitar, M
Citation: S. Ibrahim et al., 11q23 Abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses, AM J CLIN P, 114(5), 2000, pp. 793-797
Authors:
Molldrem, JJ
Lee, PP
Wang, CQ
Felio, K
Kantarjian, HM
Champlin, RE
Davis, MM
Citation: Jj. Molldrem et al., Evidence that specific T lymphocytes may participate in the elimination ofchronic myelogenous leukemia, NAT MED, 6(9), 2000, pp. 1018-1023
Authors:
Reuben, JM
Lee, BN
Johnson, H
Fritsche, H
Kantarjian, HM
Talpaz, M
Citation: Jm. Reuben et al., Restoration of Th1 cytokine synthesis by T cells of patients with chronic myelogenous leukemia in cytogenetic and hematologic remission with interferon-alpha, CLIN CANC R, 6(5), 2000, pp. 1671-1677
Authors:
Tannir, NM
Talpaz, M
Ghazal, H
Proothi, S
Kantarjian, HM
Citation: Nm. Tannir et al., Acute pancreatitis associated with interferon alpha therapy for chronic myelogenous leukemia, LEUK LYMPH, 39(5-6), 2000, pp. 647-650